As of June 2012, the FDA has not issued a definitive timeframe for all patients to end Fosamax use. However, in May 2012 the FDA did release a new study that discussed the pros and cons of long-term Fosamax use.
The study, published in the New England Journal of Medicine, found that there may be little benefit to continuing the use of bisphosphonate drugs such as Fosamax for more than three to five years. While there may be little benefit beyond three to five years of Fosamax use, the risks of serious side effects—such as atypical femur fractures and osteonecrosis of the jaw—do not diminish.
The FDA stopped short of saying that all patients should discontinue Fosamax use at the five-year mark. Instead, the agency urged patients and doctors to conduct individual risk-benefit assessments, and to be cautious about the long-term use of bisphosphonates because of the potential for injuries.
If you have been hurt by Fosamax, then it is important to contact a Milwaukee class action law firm for more information about your rights. An experienced Milwaukee Fosamax lawyer will help you understand your rights, see whether you qualify to join a class action lawsuit, and estimate what your recovery may be for your injuries. To learn more, please contact an experienced Milwaukee drug injury lawyer from Hupy and Abraham at 1-800-800-5678 or 1-414-223-4800.